{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:35:06Z","timestamp":1787312106229,"version":"build-2736575974"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172154"],"award-info":[{"award-number":["82172154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Observational studies have indicated a potential association between autoimmune diseases and the occurrence of sepsis, with an increased risk of mortality among affected patients. However, whether a causal relationship exists between the two remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the Mendelian randomization (MR) study, we accessed exposure Genome-wide association study (GWAS) data from both the MRC Integrative Epidemiology Unit (MRC-IEU) and the FinnGen consortium. GWAS data for sepsis and its 28-day mortality were obtained from MRC-IEU. We employed univariable, multivariable, and reverse MR analyses to explore potential associations between autoimmune disorders and sepsis and its 28-day mortality. Additionally, a two-step mediation MR analysis was performed to investigate indirect factors possibly influencing the relationship between autoimmune disorders and sepsis. Afterward, we conducted an observational analysis to further explore the relationship between autoimmune disease and occurrence as well as 28-day mortality of sepsis using a real-world database (the MIMIC-IV database). A cohort of 2537 patients diagnosed with autoimmune disease were extracted from the database for analysis. Multivariable logistic regression models were used to confirm the association between autoimmune diseases and the occurrence of sepsis, as well as the 28-day mortality associated with sepsis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In univariable MR analysis, there appeared to be causal relationships between genetically predicted type 1 diabetes (OR\u2009=\u20091.036, 95% CI\u2009=\u20091.023\u20131.048,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20099.130E-09), rheumatoid arthritis (OR\u2009=\u20091.077, 95% CI\u2009=\u20091.058\u20131.097,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20091.00E-15) and sepsis, while a potential causal link was observed between celiac disease and sepsis (OR\u2009=\u20091.013, 95% CI\u2009=\u20091.002\u20131.024,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.026). In a subsequent multivariable MR analysis, only rheumatoid arthritis was found to be independently associated with the risk of sepsis (OR\u2009=\u20091.138, 95% CI\u2009=\u20091.044\u20131.240,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20093.36E-03). Furthermore, there was no causal link between autoimmune disorders and 28-day mortality from sepsis. In reverse MR analysis, sepsis was suggested to potentially trigger the onset of psoriasis (OR\u2009=\u20091.084, 95% CI\u2009=\u20091.040\u20131.131,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20091.488E-04). In the real-world observational study, adjusting for multiple confounders, rheumatoid arthritis (OR\u2009=\u20091.34, 95% CI\u2009=\u20091.11\u20131.64,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003) and multiple sclerosis (OR\u2009=\u20091.31, 95% CI\u2009=\u20091.03\u20131.68,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02) were associated with a higher risk of sepsis. In addition, we did not find that autoimmune diseases were associated with 28-day mortality from sepsis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both in observational and MR analysis, only rheumatoid arthritis is highly correlated with occurrence of sepsis. However, autoimmune disease was not associated with an increased 28-day mortality in patient with sepsis. Sepsis may increase the risk of developing psoriasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-023-04763-5","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T15:01:54Z","timestamp":1701788514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Association of autoimmune diseases with the occurrence and 28-day mortality of sepsis: an observational and Mendelian randomization study"],"prefix":"10.1186","volume":"27","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenliang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"issue":"3","key":"4763_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nrg.2015.33","volume":"17","author":"M Gutierrez-Arcelus","year":"2016","unstructured":"Gutierrez-Arcelus M, Rich SS, Raychaudhuri S. Autoimmune diseases - connecting risk alleles with molecular traits of the immune system. Nat Rev Genet. 2016;17(3):160\u201374.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"4763_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jaut.2007.07.009","volume":"29","author":"IA Tsonis","year":"2007","unstructured":"Tsonis IA, Avrameas S, Moutsopoulos HM. Autoimmunity and pathophysiology. J Autoimmun. 2007;29(4):203\u20135.","journal-title":"J Autoimmun"},{"issue":"10","key":"4763_CR3","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1093\/rheumatology\/kez103","volume":"58","author":"MG Tektonidou","year":"2019","unstructured":"Tektonidou MG, Dasgupta A, Ward MM. Interhospital variation in mortality among patients with systemic lupus erythematosus and sepsis in the USA. Rheumatology (Oxford). 2019;58(10):1794\u2013801.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"4763_CR4","first-page":"338","volume":"30","author":"JM Ant\u00f3n","year":"2012","unstructured":"Ant\u00f3n JM, Castro P, Espinosa G, Marcos M, Gand\u00eda M, Merch\u00e1n R, et al. Mortality and long term survival prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit: a retrospective study. Clin Exp Rheumatol. 2012;30(3):338\u201344.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"4763_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/aje\/kwv292","volume":"183","author":"NR Rose","year":"2016","unstructured":"Rose NR. Prediction and prevention of autoimmune disease in the 21st century: a review and preview. Am J Epidemiol. 2016;183(5):403\u20136.","journal-title":"Am J Epidemiol"},{"issue":"10391","key":"4763_CR6","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","volume":"401","author":"N Conrad","year":"2023","unstructured":"Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN, et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023;401(10391):1878\u201390.","journal-title":"Lancet"},{"issue":"10141","key":"4763_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","volume":"392","author":"M Cecconi","year":"2018","unstructured":"Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392(10141):75\u201387.","journal-title":"Lancet"},{"issue":"10219","key":"4763_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global burden of disease study. Lancet. 2020;395(10219):200\u201311.","journal-title":"Lancet"},{"issue":"1","key":"4763_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13054-018-2157-z","volume":"22","author":"KE Rudd","year":"2018","unstructured":"Rudd KE, Kissoon N, Limmathurotsakul D, Bory S, Mutahunga B, Seymour CW, et al. The global burden of sepsis: barriers and potential solutions. Crit Care. 2018;22(1):232.","journal-title":"Crit Care"},{"issue":"8","key":"4763_CR10","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/acr.22575","volume":"67","author":"MG Tektonidou","year":"2015","unstructured":"Tektonidou MG, Wang Z, Dasgupta A, Ward MM. Burden of serious infections in adults with systemic lupus erythematosus: a national population-based study, 1996\u20132011. Arthritis Care Res (Hoboken). 2015;67(8):1078\u201385.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"4763_CR11","first-page":"1317","volume":"24","author":"B Godeau","year":"1997","unstructured":"Godeau B, Mortier E, Roy PM, Chevret S, Bouachour G, Schlemmer B, et al. Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients. J Rheumatol. 1997;24(7):1317\u201323.","journal-title":"J Rheumatol"},{"issue":"18","key":"4763_CR12","first-page":"837","volume":"25","author":"G Bouachour","year":"1996","unstructured":"Bouachour G, Roy PM, Tirot P, Guerin O, Gouello JP, Alquier P. Prognosis of systemic diseases diagnosed in intensive care units. Presse Med. 1996;25(18):837\u201341.","journal-title":"Presse Med"},{"issue":"4","key":"4763_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00134-005-2563-y","volume":"31","author":"M Moreels","year":"2005","unstructured":"Moreels M, M\u00e9lot C, Leeman M. Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit. Intensive Care Med. 2005;31(4):591\u20133.","journal-title":"Intensive Care Med"},{"issue":"10","key":"4763_CR14","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/rheumatology\/keg322","volume":"42","author":"BA Cruz","year":"2003","unstructured":"Cruz BA, Ramanoelina J, Mahr A, Cohen P, Mouthon L, Cohen Y, et al. Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. Rheumatology (Oxford). 2003;42(10):1183\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"4763_CR15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.autrev.2012.06.002","volume":"12","author":"OL Quintero","year":"2013","unstructured":"Quintero OL, Rojas-Villarraga A, Mantilla RD, Anaya JM. Autoimmune diseases in the intensive care unit. An update Autoimmun Rev. 2013;12(3):380\u201395.","journal-title":"An update Autoimmun Rev"},{"issue":"5","key":"4763_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.7224\/1537-2073.2014-035","volume":"17","author":"RE Nelson","year":"2015","unstructured":"Nelson RE, Xie Y, DuVall SL, Butler J, Kamauu AW, Knippenberg K, et al. Multiple sclerosis and risk of infection-related hospitalization and death in US veterans. Int J MS Care. 2015;17(5):221\u201330.","journal-title":"Int J MS Care"},{"issue":"8","key":"4763_CR17","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/ene.12130","volume":"20","author":"S Montgomery","year":"2013","unstructured":"Montgomery S, Hillert J, Bahmanyar S. Hospital admission due to infections in multiple sclerosis patients. Eur J Neurol. 2013;20(8):1153\u201360.","journal-title":"Eur J Neurol"},{"issue":"11","key":"4763_CR18","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula P, Del Greco MF, Pattaro C, K\u00f6ttgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol. 2016;27(11):3253\u201365.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4763_CR19","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/ndt\/gfq098","volume":"25","author":"M Verduijn","year":"2010","unstructured":"Verduijn M, Siegerink B, Jager KJ, Zoccali C, Dekker FW. Mendelian randomization: Use of genetics to enable causal inference in observational studies. Nephrol Dial Transplant. 2010;25(5):1394\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"4763_CR20","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.","journal-title":"Elife"},{"issue":"3","key":"4763_CR21","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755\u201364.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"4763_CR22","doi-asserted-by":"publisher","first-page":"7659","DOI":"10.1038\/s41598-022-11720-9","volume":"12","author":"D Tian","year":"2022","unstructured":"Tian D, Zhang L, Zhuang Z, Huang T, Fan D. A two-sample Mendelian randomization analysis of modifiable risk factors and intracranial aneurysms. Sci Rep. 2022;12(1):7659.","journal-title":"Sci Rep"},{"key":"4763_CR23","doi-asserted-by":"publisher","first-page":"n2233","DOI":"10.1136\/bmj.n2233","volume":"375","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. 2021;375:n2233.","journal-title":"BMJ"},{"issue":"10","key":"4763_CR24","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10654-018-0424-6","volume":"33","author":"S Burgess","year":"2018","unstructured":"Burgess S, Labrecque JA. Mendelian randomization with a binary exposure variable: interpretation and presentation of causal estimates. Eur J Epidemiol. 2018;33(10):947\u201352.","journal-title":"Eur J Epidemiol"},{"key":"4763_CR25","unstructured":"Consortium TF, https:\/\/www.finngen.fi\/fi. (Accessed 16 July 2023)."},{"issue":"5","key":"4763_CR26","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/annrheumdis-2020-219065","volume":"80","author":"E Ha","year":"2021","unstructured":"Ha E, Bae SC, Kim K. Large-scale meta-analysis across East Asian and European populations updated genetic architecture and variant-driven biology of rheumatoid arthritis, identifying 11 novel susceptibility loci. Ann Rheum Dis. 2021;80(5):558\u201365.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"4763_CR27","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ng.3434","volume":"47","author":"J Bentham","year":"2015","unstructured":"Bentham J, Morris DL, Graham DSC, Pinder CL, Tombleson P, Behrens TW, et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet. 2015;47(12):1457\u201364.","journal-title":"Nat Genet"},{"issue":"9","key":"4763_CR28","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359","volume":"47","author":"JZ Liu","year":"2015","unstructured":"Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47(9):979\u201386.","journal-title":"Nat Genet"},{"issue":"4","key":"4763_CR29","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2337\/db19-0831","volume":"69","author":"V Forgetta","year":"2020","unstructured":"Forgetta V, Manousaki D, Istomine R, Ross S, Tessier MC, Marchand L, et al. Rare genetic variants of large effect influence risk of type 1 diabetes. Diabetes. 2020;69(4):784\u201395.","journal-title":"Diabetes"},{"issue":"12","key":"4763_CR30","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ng.998","volume":"43","author":"G Trynka","year":"2011","unstructured":"Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, Szperl A, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet. 2011;43(12):1193\u2013201.","journal-title":"Nat Genet"},{"issue":"12","key":"4763_CR31","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ng.2467","volume":"44","author":"LC Tsoi","year":"2012","unstructured":"Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, Capon F, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet. 2012;44(12):1341\u20138.","journal-title":"Nat Genet"},{"issue":"7","key":"4763_CR32","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ng.2667","volume":"45","author":"A Cortes","year":"2013","unstructured":"Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, Leo P, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet. 2013;45(7):730\u20138.","journal-title":"Nat Genet"},{"issue":"11","key":"4763_CR33","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ng.2770","volume":"45","author":"AH Beecham","year":"2013","unstructured":"Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013;45(11):1353\u201360.","journal-title":"Nat Genet"},{"key":"4763_CR34","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.1038\/ncomms9019","volume":"6","author":"HJ Cordell","year":"2015","unstructured":"Cordell HJ, Han Y, Mells GF, Li Y, Hirschfield GM, Greene CS, et al. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Nat Commun. 2015;6:8019.","journal-title":"Nat Commun"},{"key":"4763_CR35","unstructured":"Ben E, Matthew L, Tessa A, Yi L, Peter M, Jon H et al. The MRC IEU OpenGWAS data infrastructure. bioRxiv 2020:2020.2008.2010.244293."},{"issue":"1","key":"4763_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13054-019-2357-1","volume":"23","author":"M Sheth","year":"2019","unstructured":"Sheth M, Benedum CM, Celi LA, Mark RG, Markuzon N. The association between autoimmune disease and 30-day mortality among sepsis ICU patients: a cohort study. Crit Care. 2019;23(1):93.","journal-title":"Crit Care"},{"issue":"8","key":"4763_CR37","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s41562-023-01646-1","volume":"7","author":"CJ Ye","year":"2023","unstructured":"Ye CJ, Kong LJ, Wang YY, Dou C, Zheng J, Xu M, et al. Mendelian randomization evidence for the causal effects of socio-economic inequality on human longevity among Europeans. Nat Hum Behav. 2023;7(8):1357\u201370.","journal-title":"Nat Hum Behav"},{"key":"4763_CR38","unstructured":"Consortium TF, https:\/\/risteys.finregistry.fi\/endpoints\/AB1_SEPSIS. (Accessed 16 July 2023)."},{"issue":"4","key":"4763_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/joim.12395","volume":"278","author":"L Wang","year":"2015","unstructured":"Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278(4):369\u201395.","journal-title":"J Intern Med"},{"issue":"5","key":"4763_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nri.2017.143","volume":"18","author":"CA Dendrou","year":"2018","unstructured":"Dendrou CA, Petersen J, Rossjohn J, Fugger L. HLA variation and disease. Nat Rev Immunol. 2018;18(5):325\u201339.","journal-title":"Nat Rev Immunol"},{"issue":"R2","key":"4763_CR41","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","volume":"27","author":"G Hemani","year":"2018","unstructured":"Hemani G, Bowden J, Davey SG. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27(R2):R195-r208.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"4763_CR42","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985\u201398.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"4763_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377\u201389.","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"4763_CR44","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"issue":"29","key":"4763_CR45","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1002\/sim.7492","volume":"36","author":"JMB Rees","year":"2017","unstructured":"Rees JMB, Wood AM, Burgess S. Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy. Stat Med. 2017;36(29):4705\u201318.","journal-title":"Stat Med"},{"issue":"1","key":"4763_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"AEW Johnson","year":"2023","unstructured":"Johnson AEW, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S, et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023;10(1):1.","journal-title":"Sci Data"},{"issue":"6","key":"4763_CR47","doi-asserted-by":"publisher","first-page":"1131.e1131","DOI":"10.1016\/j.jcrc.2014.06.027","volume":"29","author":"P Emerson","year":"2014","unstructured":"Emerson P, McPeake J, O\u2019Neill A, Gilmour H, Forrest E, Puxty A, et al. The utility of scoring systems in critically ill cirrhotic patients admitted to a general intensive care unit. J Crit Care. 2014;29(6):1131.e1131-1136.","journal-title":"J Crit Care"},{"issue":"1","key":"4763_CR48","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3109\/00365521.2015.1063153","volume":"51","author":"J Zhou","year":"2016","unstructured":"Zhou J, Zhou Y, Cao S, Li S, Wang H, Niu Z, et al. Multivariate logistic regression analysis of postoperative complications and risk model establishment of gastrectomy for gastric cancer: A single-center cohort report. Scand J Gastroenterol. 2016;51(1):8\u201315.","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"4763_CR49","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1016\/S1473-3099(19)30567-5","volume":"19","author":"I Rubio","year":"2019","unstructured":"Rubio I, Osuchowski MF, Shankar-Hari M, Skirecki T, Winkler MS, Lachmann G, et al. Current gaps in sepsis immunology: new opportunities for translational research. Lancet Infect Dis. 2019;19(12):e422\u201336.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"4763_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nyas.14333","volume":"1499","author":"F Venet","year":"2021","unstructured":"Venet F, Demaret J, Gossez M, Monneret G. Myeloid cells in sepsis-acquired immunodeficiency. Ann N Y Acad Sci. 2021;1499(1):3\u201317.","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl","key":"4763_CR51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2005.09.024","volume":"25","author":"JF Bach","year":"2005","unstructured":"Bach JF. Infections and autoimmune diseases. J Autoimmun. 2005;25(Suppl):74\u201380.","journal-title":"J Autoimmun"},{"key":"4763_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40560-019-0424-y","volume":"8","author":"L Oud","year":"2020","unstructured":"Oud L. Epidemiology and outcomes of sepsis among hospitalizations with systemic lupus erythematosus admitted to the ICU: a population-based cohort study. J Intensive Care. 2020;8:3.","journal-title":"J Intensive Care"},{"issue":"1","key":"4763_CR53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1385\/CRIAI:25:1:29","volume":"25","author":"G Zandman-Goddard","year":"2003","unstructured":"Zandman-Goddard G, Shoenfeld Y. SLE and infections. Clin Rev Allergy Immunol. 2003;25(1):29\u201340.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"4763_CR54","doi-asserted-by":"publisher","first-page":"e000510","DOI":"10.1136\/lupus-2021-000510","volume":"8","author":"JF Simard","year":"2021","unstructured":"Simard JF, Rossides M, Gunnarsson I, Svenungsson E, Arkema EV. Infection hospitalisation in systemic lupus in Sweden. Lupus Sci Med. 2021;8(1):e000510.","journal-title":"Lupus Sci Med"},{"issue":"6","key":"4763_CR55","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/art.39070","volume":"67","author":"CH Feldman","year":"2015","unstructured":"Feldman CH, Hiraki LT, Winkelmayer WC, Marty FM, Franklin JM, Kim SC, et al. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Arthritis Rheumatol. 2015;67(6):1577\u201385.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"4763_CR56","doi-asserted-by":"publisher","first-page":"e000935","DOI":"10.1136\/rmdopen-2019-000935","volume":"5","author":"B Mehta","year":"2019","unstructured":"Mehta B, Pedro S, Ozen G, Kalil A, Wolfe F, Mikuls T, et al. Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study. RMD Open. 2019;5(1):e000935.","journal-title":"RMD Open"},{"issue":"2","key":"4763_CR57","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.crohns.2012.02.015","volume":"7","author":"AN Ananthakrishnan","year":"2013","unstructured":"Ananthakrishnan AN, McGinley EL. Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. J Crohns Colitis. 2013;7(2):107\u201312.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"4763_CR58","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","volume":"4","author":"GR Lichtenstein","year":"2006","unstructured":"Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Chen DM, et al. Serious infections and mortality in association with therapies for Crohn\u2019s disease: TREAT registry. Clin Gastroenterol Hepatol. 2006;4(5):621\u201330.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"4763_CR59","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2337\/dc17-2131","volume":"41","author":"IM Carey","year":"2018","unstructured":"Carey IM, Critchley JA, DeWilde S, Harris T, Hosking FJ, Cook DG. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care. 2018;41(3):513\u201321.","journal-title":"Diabetes Care"},{"issue":"8","key":"4763_CR60","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.jid.2018.01.039","volume":"138","author":"J Takeshita","year":"2018","unstructured":"Takeshita J, Shin DB, Ogdie A, Gelfand JM. Risk of serious infection, opportunistic infection, and herpes zoster among patients with psoriasis in the united Kingdom. J Invest Dermatol. 2018;138(8):1726\u201335.","journal-title":"J Invest Dermatol"},{"issue":"10","key":"4763_CR61","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1136\/ard.2008.098822","volume":"69","author":"A Fouque-Aubert","year":"2010","unstructured":"Fouque-Aubert A, Jette-Paulin L, Combescure C, Basch A, Tebib J, Gossec L. Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials. Ann Rheum Dis. 2010;69(10):1756\u201361.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"4763_CR62","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1111\/jth.15313","volume":"19","author":"X Liu","year":"2021","unstructured":"Liu X, Arfman T, Wichapong K, Reutelingsperger CPM, Voorberg J, Nicolaes GAF. PAD4 takes charge during neutrophil activation: Impact of PAD4 mediated NET formation on immune-mediated disease. J Thromb Haemost. 2021;19(7):1607\u201317.","journal-title":"J Thromb Haemost"},{"issue":"11","key":"4763_CR63","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/nm.2053","volume":"15","author":"J Xu","year":"2009","unstructured":"Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, et al. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009;15(11):1318\u201321.","journal-title":"Nat Med"},{"issue":"4","key":"4763_CR64","doi-asserted-by":"publisher","first-page":"R151","DOI":"10.1186\/cc11466","volume":"16","author":"DJ Dwivedi","year":"2012","unstructured":"Dwivedi DJ, Toltl LJ, Swystun LL, Pogue J, Liaw KL, Weitz JI, et al. Prognostic utility and characterization of cell-free DNA in patients with severe sepsis. Crit Care. 2012;16(4):R151.","journal-title":"Crit Care"},{"issue":"2","key":"4763_CR65","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/cc4894","volume":"10","author":"A Rhodes","year":"2006","unstructured":"Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care. 2006;10(2):R60.","journal-title":"Crit Care"},{"issue":"4","key":"4763_CR66","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1186\/cc11442","volume":"16","author":"W Meng","year":"2012","unstructured":"Meng W, Paunel-G\u00f6rg\u00fcl\u00fc A, Floh\u00e9 S, Hoffmann A, Witte I, MacKenzie C, et al. Depletion of neutrophil extracellular traps in vivo results in hypersusceptibility to polymicrobial sepsis in mice. Crit Care. 2012;16(4):R137.","journal-title":"Crit Care"},{"issue":"4","key":"4763_CR67","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nm1565","volume":"13","author":"SR Clark","year":"2007","unstructured":"Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med. 2007;13(4):463\u20139.","journal-title":"Nat Med"},{"issue":"5","key":"4763_CR68","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1158\/1535-7163.MCT-10-0868","volume":"10","author":"M Faibish","year":"2011","unstructured":"Faibish M, Francescone R, Bentley B, Yan W, Shao R. A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers. Mol Cancer Ther. 2011;10(5):742\u201351.","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"4763_CR69","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.7150\/ijbs.67587","volume":"18","author":"K Tizaoui","year":"2022","unstructured":"Tizaoui K, Yang JW, Lee KH, Kim JH, Kim M, Yoon S, et al. The role of YKL-40 in the pathogenesis of autoimmune diseases: a comprehensive review. Int J Biol Sci. 2022;18(9):3731\u201346.","journal-title":"Int J Biol Sci"},{"issue":"10","key":"4763_CR70","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.imbio.2013.04.010","volume":"218","author":"B Kornblit","year":"2013","unstructured":"Kornblit B, Hellemann D, Munthe-Fog L, Bonde J, Str\u00f8m JJ, Madsen HO, et al. Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis-experience from two prospective cohorts. Immunobiology. 2013;218(10):1227\u201334.","journal-title":"Immunobiology"},{"issue":"4","key":"4763_CR71","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/rheumatology\/kez349","volume":"59","author":"S Subesinghe","year":"2020","unstructured":"Subesinghe S, Kleymann A, Rutherford AI, Bechman K, Norton S, Benjamin GJ. The association between lymphopenia and serious infection risk in rheumatoid arthritis. Rheumatology (Oxford). 2020;59(4):762\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"4763_CR72","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.21037\/apm-20-1777","volume":"9","author":"Z Li","year":"2020","unstructured":"Li Z, Xiao Y, Zhang L. Application of procalcitonin, white blood cell count and neutrophil-to-lymphocyte ratio in the diagnosis of systemic lupus erythematosus with a bacterial infection. Ann Palliat Med. 2020;9(6):3870\u20136.","journal-title":"Ann Palliat Med"},{"key":"4763_CR73","doi-asserted-by":"publisher","first-page":"5089815","DOI":"10.1155\/2017\/5089815","volume":"2017","author":"Q Guan","year":"2017","unstructured":"Guan Q, Gao X, Wang J, Sun Y, Shekhar S. Cytokines in Autoimmune Disease. Mediators Inflamm. 2017;2017:5089815.","journal-title":"Mediators Inflamm"},{"issue":"5","key":"4763_CR74","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","volume":"39","author":"BG Chousterman","year":"2017","unstructured":"Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017;39(5):517\u201328.","journal-title":"Semin Immunopathol"},{"issue":"6","key":"4763_CR75","first-page":"905","volume":"77","author":"AI Rutherford","year":"2018","unstructured":"Rutherford AI, Subesinghe S, Hyrich KL, Galloway JB. Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British society for rheumatology biologics register for rheumatoid arthritis. Ann Rheum Dis. 2018;77(6):905\u201310.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4763_CR76","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1001\/jamaneurol.2019.3365","volume":"77","author":"G Luna","year":"2020","unstructured":"Luna G, Alping P, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, et al. Infection risks among patients with multiple sclerosis treated with fingolimod, natalizumab, rituximab, and injectable therapies. JAMA Neurol. 2020;77(2):184\u201391.","journal-title":"JAMA Neurol"},{"issue":"2","key":"4763_CR77","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.autrev.2017.11.015","volume":"17","author":"JJ Tudesq","year":"2018","unstructured":"Tudesq JJ, Cartron G, Rivi\u00e8re S, Morquin D, Iordache L, Mahr A, et al. Clinical and microbiological characteristics of the infections in patients treated with rituximab for autoimmune and\/or malignant hematological disorders. Autoimmun Rev. 2018;17(2):115\u201324.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"4763_CR78","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.idc.2020.02.001","volume":"34","author":"S Shoor","year":"2020","unstructured":"Shoor S. Risk of serious infection associated with agents that target T-cell activation and interleukin-17 and interleukin-23 cytokines. Infect Dis Clin North Am. 2020;34(2):179\u201389.","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"4763_CR79","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/1744666X.2020.1763793","volume":"16","author":"MRW Barber","year":"2020","unstructured":"Barber MRW, Clarke AE. Systemic lupus erythematosus and risk of infection. Expert Rev Clin Immunol. 2020;16(5):527\u201338.","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"4763_CR80","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0002-9610(01)00754-1","volume":"182","author":"S Ono","year":"2001","unstructured":"Ono S, Ueno C, Aosasa S, Tsujimoto H, Seki S, Mochizuki H. Severe sepsis induces deficient interferon-gamma and interleukin-12 production, but interleukin-12 therapy improves survival in peritonitis. Am J Surg. 2001;182(5):491\u20137.","journal-title":"Am J Surg"},{"key":"4763_CR81","first-page":"337","volume":"8","author":"JA Carrizosa","year":"2017","unstructured":"Carrizosa JA, Aponte J, Cartagena D, Cervera R, Ospina MT, Sanchez A. Factors associated with mortality in patients with autoimmune diseases admitted to the intensive care unit in Bogota. Colombia Front Immunol. 2017;8:337.","journal-title":"Colombia Front Immunol"},{"issue":"7","key":"4763_CR82","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17(7):407\u201320.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"4763_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102743","volume":"20","author":"ZX Xiao","year":"2021","unstructured":"Xiao ZX, Miller JS, Zheng SG. An updated advance of autoantibodies in autoimmune diseases. Autoimmun Rev. 2021;20(2): 102743.","journal-title":"Autoimmun Rev"},{"issue":"13","key":"4763_CR84","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.3390\/ijms23136955","volume":"23","author":"S Zhou","year":"2022","unstructured":"Zhou S, Yao Z. Roles of infection in Psoriasis. Int J Mol Sci. 2022;23(13):6955.","journal-title":"Int J Mol Sci"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04763-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04763-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04763-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T16:30:36Z","timestamp":1701793836000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04763-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4763"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04763-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3380956\/v1","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,5]]},"assertion":[{"value":"24 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies had been approved by a relevant ethical review board and participants had given informed consent. Ethical approval was not required because of the public characteristics of the data of GWAS.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have stated that they have no Competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"476"}}